A007570 Stock Overview
Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Ilyang Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩13,680.00 |
| 52 Week High | ₩18,100.00 |
| 52 Week Low | ₩13,130.00 |
| Beta | -0.27 |
| 1 Month Change | -7.25% |
| 3 Month Change | -5.00% |
| 1 Year Change | -19.77% |
| 3 Year Change | -65.50% |
| 5 Year Change | -51.23% |
| Change since IPO | 135.21% |
Recent News & Updates
Recent updates
Is Ilyang PharmaceuticalLtd (KRX:007570) A Risky Investment?
Apr 04
Should You Be Adding Ilyang PharmaceuticalLtd (KRX:007570) To Your Watchlist Today?
Mar 14Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely
Mar 14Declining Stock and Decent Financials: Is The Market Wrong About Ilyang Pharmaceutical Co.,Ltd (KRX:007570)?
Feb 22Did Business Growth Power Ilyang PharmaceuticalLtd's (KRX:007570) Share Price Gain of 159%?
Feb 01Is Ilyang Pharmaceutical Co.,Ltd's (KRX:007570) Shareholder Ownership Skewed Towards Insiders?
Jan 11
Here's Why Ilyang PharmaceuticalLtd (KRX:007570) Can Manage Its Debt Responsibly
Dec 24A Look At The Intrinsic Value Of Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
Dec 06Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 18Shareholder Returns
| A007570 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -1.2% | 5.5% | 3.4% |
| 1Y | -19.8% | 8.1% | 7.1% |
Price Volatility
| A007570 volatility | |
|---|---|
| A007570 Average Weekly Movement | 2.3% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A007570 has not had significant price volatility in the past 3 months.
Volatility Over Time: A007570's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1946 | 655 | Dong-Yeon Kim | www.ilyang.co.kr |
Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages.
Ilyang Pharmaceutical Co.,Ltd Fundamentals Summary
| A007570 fundamental statistics | |
|---|---|
| Market cap | ₩245.85b |
| Earnings (TTM) | -₩2.51b |
| Revenue (TTM) | ₩370.54b |
0.7x
P/S Ratio-98.1x
P/E RatioIs A007570 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A007570 income statement (TTM) | |
|---|---|
| Revenue | ₩370.54b |
| Cost of Revenue | ₩170.52b |
| Gross Profit | ₩200.02b |
| Other Expenses | ₩202.52b |
| Earnings | -₩2.51b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -139.46 |
| Gross Margin | 53.98% |
| Net Profit Margin | -0.68% |
| Debt/Equity Ratio | 32.0% |
How did A007570 perform over the long term?
See historical performance and comparison